Accelerator Program
Funding Amount
Not stated
Deadline
Deadline not published
Grant Type
Foundation
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Geography
- Based in the US
Other requirements
- _You can learn more about this opportunity by visiting the funder's [website](https://www.scn2a.org/professionals.html)._
Overview
FamilieSCN2A
The global leader in SCN2A-related autism & epilepsy research, advocacy, and community.
Accelerator Program
The FamilieSCN2A Accelerator Program is an investment program in which funding is invested in a for-profit company on a competitive basis for drug development projects. The program is designed to address commercial funding gaps by de-risking therapeutic development for SCN2A Related Disorders. We fund projects that show promise for subsequent commercial development.
Eligibility
_You can learn more about this opportunity by visiting the funder's website._
- Any scientist working at a for-profit company based in the US.
What The FAMILIESCN2A Foundation Inc actually gave
Source: IRS Form 990, 2025
- Grants in 2025
- 6
- Total given
- $891K
- Median grant
- $62K
- Range
- $10K–$456K
- By dollars: Illinois 51%, Iowa 29%, California 14%. Top recipient cities: Chicago, IL; Iowa City, IA; Los Angeles, CA.
- 0% of grants with a stated purpose were for general or operating support.
Example grants
Purdue University · Chicago, IL
Scn2a research
$456K
University of Iowa · Iowa City, IA
Scn2a research
$261K
The Regents of the University of California San Francisco · Los Angeles, CA
Scn2a research
$68K
The Regents of Uc · Oakland, CA
Scn2a research
$56K
University of Colorado Denver · Denver, CO
Scn2a research
$39K
Focus Areas & Funding Uses
Fields of Work
- Science research
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
Pilot Projects to Enhance the Human Virome Program (R03 Clinical Trials Not Allowed)
National Institutes of Health
Amount
$50,000 - $100,000
Deadline
November 10, 2026
Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
National Institutes of Health
Amount
$40,000,000 total
Deadline
November 10, 2026
DoW Vision, Translational Research Award
Defense Health Agency Contracting Activity - DHACA
Amount
$1,600,000 total
Deadline
November 12, 2026
ROSES 2025: C.2 Solar System Science
NASA Headquarters
Amount
Varies
Deadline
November 12, 2026
DoW Vision, Investigator-Initiated Research Award
Defense Health Agency Contracting Activity - DHACA
Amount
$4,400,000 total
Deadline
November 12, 2026
DoW Vision, Clinical Trial Award
Defense Health Agency Contracting Activity - DHACA
Amount
$2,600,000 total
Deadline
November 12, 2026
Ready to apply for Accelerator Program?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found Accelerator Program. Now let's win it.